ChemDiv Acquires Clinical Trial Firm | April 27, 2009 Issue - Vol. 87 Issue 17 | Chemical & Engineering News
Volume 87 Issue 17 | p. 15 | Concentrates
Issue Date: April 27, 2009

ChemDiv Acquires Clinical Trial Firm

Department: Business

ChemDiv, a chemistry-based contract research firm, has acquired Prudentas, a Moscow-based company that conducts Phase I through IV clinical studies in Eastern Europe. ChemDiv, which is headquartered in San Diego but has most of its operations in Russia, says its investment capitalizes on the growing trend of conducting clinical trials in Eastern Europe. ChemDiv CEO Nikolay Savchuk expects Prudentas to work well with ChemDiv's Chemical Diversity Research Institute and its Drugs Technology subsidiary, a provider of formulation services.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment